Physician profile
Addison P Roberts
NPI 1326494717
$8,894.15
in general payments reported to CMS, 2019-2025
24 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $139 · 2021: $34.96 · 2022: $3,248 · 2023: $3,839 · 2024: $115 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,794 · Food and Beverage: $1,371 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,794.49 |
| Food and Beverage | $1,371.37 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,735.14 | 2019-2025 | Da Vinci Surgical System, Davinci Xi, Da Vinci Sp |
| Davol INC. | $1,350.56 | 2022-2023 | Phasix Mesh |
| Becton, Dickinson and Company | $910.56 | 2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $129.57 | 2024-2025 | Gattex |
| Polynovo North America LLC | $115.39 | 2023-2025 | Novosorb Btm |
| Ethicon US, LLC | $109.22 | 2022 | |
| Convatec INC. | $67.40 | 2019 | |
| Tela Bio, INC. | $55.05 | 2020 | |
| Cardiovascular Systems INC. | $51.64 | 2019 | |
| Stryker Corporation | $45.42 | 2023 | Spy-Phi System |
| Heron Therapeutics, INC. | $45.30 | 2023-2024 | Zynrelef, Aponvie |
| Medtronic, INC. | $41.23 | 2021-2025 | Interstim |
| Vertex Pharmaceuticals Incorporated | $30.59 | 2025 | |
| Conmed Corporation | $24.66 | 2025 | Airseal |
| Abbvie INC. | $23.37 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $22.02 | 2025 | Titan Sgs Bailout Chuck |
| Merck Sharp & Dohme LLC | $21.08 | 2024 | Bridion |
| Solventum Corporation | $20.77 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Innocoll Pharmaceuticals Limited | $19.43 | 2021 | |
| W. L. Gore & Associates, INC. | $19.31 | 2023 | Gore Synecor Biomaterial |
| Allergan, INC. | $18.44 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.69 | 2022 | |
| Amgen INC. | $11.83 | 2019 | |
| Pfizer INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Addison Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.